Antimicrobial Agents and Chemotherapy · 2017 · 23 citations · 16 references
PharmacyInfectious DiseasesMedicinal ChemistryDrug DiscoveryMolecular VirologyVirologyAntiviral AgentsAntiviral PharmacologyAntiviral TherapyViral HepatitisViral Hepatitis TreatmentViral Rna BiologyAntiviral Drug DesignAntiviral Structure-activity RelationshipsAntiviral TherapeuticsHepatitis B Virus ReplicationRibonuclease ChemistryTherapeutic Target IdentificationViral Replication ControlViral Replication Inhibitors
Hepatitis B virus (HBV) RNase H (RNH) is an appealing therapeutic target due to its essential role in viral replication. RNH inhibitors (RNHIs) could help to more effectively control HBV infections. Here, we report 3-hydroxypyrimidine-2,4-diones as novel HBV RNHIs with antiviral activity. We synthesized and tested 52 analogs and found 4 that inhibit HBV RNH activity in infected cells. Importantly, 2 of these compounds inhibited HBV replication in the low micromolar range.
16
Stephanie K. Ladner, Michaël Otto, Christopher S. Barker et al. · Antimicrobial Agents and Chemotherapy · 1997 · 635 citations · Full text
Sanjeev Kumar V. Vernekar, Zheng Liu, Éva Nagy et al. · Journal of Medicinal Chemistry · 2014 · 135 citations · Full text